Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma-Reference-Cited by-同舟云学术

Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma

Published:2023-11-21 Issue: Volume: Page:
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Gregucci Fabiana^ORCID,Di Guglielmo Fiorella Cristina,Surgo Alessia,Carbonara Roberta,Laera Letizia,Ciliberti Maria Paola,Gentile Maria Annunziata,Calbi Roberto,Caliandro Morena,Sasso Nicola,Davi’ Valerio,Bonaparte Ilaria,Fanelli Vincenzo,Giraldi David,Tortora Romina,Internò Valeria,Giuliani Francesco,Surico Giammarco,Signorelli Francesco,Lombardi Giuseppe,Fiorentino Alba

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00066-023-02172-9.pdf

Reference44 articles.

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106–130. https://doi.org/10.3322/canjclin.56.2.106

2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bog-dahn U et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. https://doi.org/10.1056/NEJMoa043330

3. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5‑year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. https://doi.org/10.1016/S1470-2045(09)70025-7

4. Biswas T, Okunieff P, Schell MC, Smudzin T, Pilcher WH, Bakos RS, Vates GE, Walter KA, Wensel A, Korones DN et al (2009) Stereotactic radiosurgery for glioblastoma: retrospective analysis. Radiat Oncol 4:11. https://doi.org/10.1186/1748-717X-4-11

5. Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD (2015) Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era. J Neurosurg 122:757–765. https://doi.org/10.3171/2014.11.JNS13295